When was FesariusTherapeutics founded?

FesariusTherapeutics was founded in 2017 and raised its 1st funding round 8 years after it was founded.

Where is FesariusTherapeutics located?

FesariusTherapeutics is headquartered in Brooklyn, United States.

How many employees does FesariusTherapeutics have?

As of Sep 30, 2026, the latest employee count at FesariusTherapeutics is 17.

Is FesariusTherapeutics a funded company?

FesariusTherapeutics is a funded company, having raised a total of $20M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 31, 2025.

When was the latest funding round of FesariusTherapeutics?

FesariusTherapeutics' latest funding was a $***** Series A round on Jun 10, 2026, with participation from 3 investors.

Where does FesariusTherapeutics rank among its competitors?

FesariusTherapeutics ranks 1st amongst 46 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was FesariusTherapeutics, which secured $20M in Jun, 2026.

Who are the top competitors of FesariusTherapeutics?

FesariusTherapeutics' top competitors include Stratum Biosciences, Hugel and PharmaResearch. Among them, FesariusTherapeutics secured the most recent funding round in June, 2026.

FesariusTherapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Dermal regeneration solutions improving patient lives through innovative hydrogel technology. This biotech startup focuses on tissue-engineered products for reconstructive and aesthetic surgery. They developed a dermal regeneration template (DRT) for wound management, addressing full-thickness skin loss. Their mission is to optimize tissue regeneration and repair with groundbreaking technologies. They aim to disrupt reconstructive surgery through quality science, compelling data, and superior products. They are committed to innovation, customer service, and improving health outcomes. Their flagship product is a novel hydrogel dermal regenerative template developed from groundbreaking technology. This solution blends scientific efficacy with clinical needs, maintaining ideal conditions in the wound bed. It supports stable vascularized tissue regeneration, mimicking the body's natural healing response. They value integrity, compassion for patient care, rigorous science, and a diverse culture. This is a B2B company.

Key Metrics

Founded Year

2017

Location

Brooklyn, United States

Stage

Series A

Total Funding

$20M in 4 rounds

Latest Funding Round

Series A, Jun 10, 2026, $*****

Investors

Jefferson Life Sciences & 4 more

Ranked

1^st among 46 active competitors

Employee Count

17 as on Sep 30, 2026

Similar Companies

Stratum Biosciences & 46 more

View FesariusTherapeutics' full profile

FesariusTherapeutics has raised a total funding of $20M over 4 rounds. Its first funding round was on Jul 31, 2025. Its latest funding round was a Series A round on Jun 10, 2026 for $*****. 3 investors participated in its latest round. FesariusTherapeutics has 5 institutional investors.

Here is the list of recent funding rounds of FesariusTherapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 10, 2026	3167615	Series A	4664470	9491864	5629602	3816208
Dec 08, 2025	7076460	Grant (prize money)	8751968	4526582	7761669	HHS
Sep 08, 2025	8734019	Grant (prize money)	6810694	4701668	8273065	HHS

Access funding benchmarks and valuations. Sign up today!

View details of FesariusTherapeutics's funding rounds and investors

The founders of FesariusTherapeutics are Yulia Sapir-Lekhovitser and Jason Spector.

Here are the details of FesariusTherapeutics' key team members:

Yulia Sapir-Lekhovitser: Co-Founder of FesariusTherapeutics.
Jason Spector: Co-Founder of FesariusTherapeutics.
Contact Info: 1 email address

View details of FesariusTherapeutics's Founder profiles and Board Members

FesariusTherapeutics' employee count trend

FesariusTherapeutics has 17 employees as of Sep 26. Here is FesariusTherapeutics's employee count trend over the years:

Employee count trend for FesariusTherapeutics

Uncover FesariusTherapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FesariusTherapeutics include Stratum Biosciences, Hugel and PharmaResearch. Here is the list of Top 10 competitors of FesariusTherapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	FesariusTherapeutics 2017, Brooklyn (United States), Series A	Dermal regeneration solutions improving patient lives through innovative hydrogel technology	$20M	New York Ventures, HHS & 3 others	55/100
2nd	Stratum Biosciences 2023, New York (United States), Seed	Provider of AI-based solutions for dermatological therapies and molecular delivery across the skin	$2M	HBS Alumni Angels of Greater New York, Skin Angels	41/100
3rd	Hugel 2001, United States, Unfunded	Developer of injectables for skin rejuvenation and aesthetic treatment	-	-	35/100
4th	PharmaResearch South Korea, Unfunded	Manufacturer of medical products utilizing DNA extracted from salmon cells	-	-	34/100
5th	Mitchell-Vance Laboratories Guilford (United States), Unfunded	Manufacturer of silicone scar sheets and topical scar treatment serum	-	-	31/100
6th	BELANO Medical 2010, Hennigsdorf (Germany), Seed	Developer of microbiome products for treating skin, throat, stomach, and wound care	-	b.value AG, Deutsche Biotech Innovativ AG	28/100
7th	TCI Lab 2001, Brazil, Unfunded	Manufacturer of topical dermatological creams and fluids for skin protection	-	-	28/100
8th	The Biobox 2012, Yorba Linda (United States), Unfunded	Umbilical cord lining stem cells provider	-	-	25/100
9th	PHYLA Petaluma (United States), Funding Raised	Online retailer of skincare products formulated to treat acne conditions	-	HHS	25/100
10th	Revanesse Versa 2012, Aurora (Canada), Unfunded	Developer of hyaluronic acid dermal filler for the treatment of facial wrinkles and folds	-	-	24/100